WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Stock Ownership - Who owns Altimmune?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Altimmune Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Raymond M. JordtChief Business Officer2026-01-253,855$5.50
$21.20kSell
M. Scot RobertsChief Scientific Officer2026-01-254,373$5.50
$24.05kSell
Vipin K. GargDirector2026-01-2517,984$5.50
$98.91kSell
Wayne PisanoDirector2026-01-085,000$4.08
$20.41kBuy
Catherine A. SohnDirector2026-01-05500$4.24
$2.12kBuy
Raymond M. JordtChief Business Officer2026-01-012,475$3.61
$8.93kSell
Diane JorkaskyDirector2025-12-29527$3.80
$2.00kBuy
John GillDirector2025-12-2312,500$4.10
$51.25kBuy
Jerome Benedict DursoDirector2025-12-2212,500$4.13
$51.56kBuy
Gregory L. WeaverChief Financial Officer2025-11-115,672$4.28
$24.28kSell

1 of 3

ALT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALT insiders and whales buy or sell their stock.

ALT Shareholders

What type of owners hold Altimmune Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Prescott Group Capital Management LLC19.03%19,837,273$122.59MInsider
Novartis Bioventures Ltd8.00%8,345,145$51.57MInsider
Vanguard Group Inc6.11%6,373,638$39.39MInstitution
Blackrock Inc6.11%6,373,259$39.39MInstitution
Mpm Bioventures III LLC6.09%6,347,614$39.23MInsider
Luke Evnin6.09%6,347,614$39.23MInsider
Healthcare Ventures VII LP4.20%4,378,057$27.06MInsider
State Street Corp3.45%3,601,255$22.26MInstitution
Venrock Healthcare Capital Partners III LP3.36%3,500,000$21.63MInsider
James H. Cavanaugh3.18%3,317,243$20.50MInsider

1 of 3

ALT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALT39.58%60.42%Net SellingNet Selling
LBRX71.88%28.12%Net Buying
LXEO67.63%9.87%Net SellingNet Selling
KROS79.60%20.40%Net SellingNet Selling
LXRX21.62%78.38%Net Selling
View Top Biotech Stocks

Altimmune Stock Ownership FAQ

Who owns Altimmune?

Altimmune (NASDAQ: ALT) is owned by 39.79% institutional shareholders, 60.74% Altimmune insiders, and 0.00% retail investors. Prescott Group Capital Management LLC is the largest individual Altimmune shareholder, owning 19.84M shares representing 19.03% of the company. Prescott Group Capital Management LLC's Altimmune shares are currently valued at $101.57M.

If you're new to stock investing, here's how to buy Altimmune stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.